Citations to this article

A unique genetic and biochemical presentation of fish-eye disease.
J A Kuivenhoven, … , P H Pritchard, J J Kastelein
J A Kuivenhoven, … , P H Pritchard, J J Kastelein
Published December 1, 1995
Citation Information: J Clin Invest. 1995;96(6):2783-2791. https://doi.org/10.1172/JCI118348.
View: Text | PDF
Research Article Article has an altmetric score of 3

A unique genetic and biochemical presentation of fish-eye disease.

Abstract

This paper describes a novel genetic defect which causes fish-eye disease in four homozygous probands and its biochemical presentation in 34 heterozygous siblings. The male index patient presented with premature coronary artery disease, corneal opacification, HDL deficiency, and a near total loss of plasma lecithin:cholesterol acyltransferase (LCAT) activity. Sequencing of the LCAT gene revealed homozygosity for a novel missense mutation resulting in an Asp131 - Asn (N131D) substitution. Heterozygotes showed a highly significant reduction of HDL-cholesterol and apolipoprotein A-I levels as compared with controls which was associated with a specific decrease of LpA-I:A-II particles. Functional assessment of this mutation revealed loss of specific activity of recombinant LCAT(N131D) against proteoliposomes. Unlike other mutations causing fish-eye disease, recombinant LCAT(N131D) also showed a 75% reduction in specific activity against LDL. These unique biochemical characteristics reveal the heterogeneity of phenotypic expression of LCAT gene defects within a range specified by complete loss of LCAT activity and the specific loss of activity against HDL. The impact of this mutation on HDL levels and HDL subclass distribution may be related to the premature coronary artery disease observed in the male probands.

Authors

J A Kuivenhoven, E J van Voorst tot Voorst, H Wiebusch, S M Marcovina, H Funke, G Assmann, P H Pritchard, J J Kastelein

×

Total citations by year

Year: 2022 2021 2019 2018 2017 2015 2014 2012 2011 2009 2005 2004 2003 2001 2000 1999 1998 1997 1996 Total
Citations: 1 2 2 2 1 2 1 4 2 2 1 1 1 5 3 3 2 6 1 42
Citation information

Citations to this article (42)

Title and authors Publication Year
A systematic review of the natural history and biomarkers of primary Lecithin:Cholesterol Acyltransferase (LCAT) deficiency
C Vitali, A Bajaj, C Nguyen, J Schnall, J Chen, K Stylianou, D Rader, M Cuchel 		Journal of lipid research 2022
LCAT deficiency: a systematic review with the clinical and genetic description of Mexican kindred
R Mehta, D Elías-López, AJ Martagón, OA Pérez-Méndez, ML Sánchez, Y Segura, MT Tusié, CA Aguilar-Salinas 		Lipids in Health and Disease 2021
Positive allosteric modulators of lecithin: Cholesterol acyltransferase adjust the orientation of the membrane-binding domain and alter its spatial free energy profile
A Niemelä, A Koivuniemi, A MacKerell 		PLoS computational biology 2021
HDL Dysfunction Caused by Mutations in apoA-I and Other Genes that are Critical for HDL Biogenesis and Remodeling
A Chroni, D Kardassis 		Current medicinal chemistry 2019
The P274S Mutation of Lecithin-Cholesterol Acyltransferase (LCAT) and Its Clinical Manifestations in a Large Kindred
N Fountoulakis, E Lioudaki, D Lygerou, EK Dermitzaki, I Papakitsou, V Kounali, AG Holleboom, S Stratigis, C Belogianni, P Syngelaki, S Stratakis, A Evangeliou, H Gakiopoulou, JA Kuivenhoven, R Wevers, E Dafnis, K Stylianou 		American journal of kidney diseases : the official journal of the National Kidney Foundation 2019
A simple and precise method to detect sterol esterification activity of lecithin/cholesterol acyltransferase by high-performance liquid chromatography
Y Wang, S Wang, L Zhang, J Zeng, R Yang, H Li, Y Tang, W Chen, J Dong 		Analytical and Bioanalytical Chemistry 2018
Interaction of lecithin:cholesterol acyltransferase with lipid surfaces and apolipoprotein A-I-derived peptides
MG Casteleijn, P Parkkila, T Viitala, A Koivuniemi 		Journal of lipid research 2018
A retractable lid in lecithin:cholesterol acyltransferase provides a structural mechanism for activation by apolipoprotein A-I
KA Manthei, J Ahn, A Glukhova, W Yuan, C Larkin, TD Manett, L Chang, JA Shayman, MJ Axley, A Schwendeman, JJ Tesmer 		The Journal of biological chemistry 2017
The effect of natural LCAT mutations on the biogenesis of HDL
P Fotakis, JA Kuivenhoven, E Dafnis, D Kardassis, VI Zannis 		Biochemistry 2015
Management of lipoprotein X and its complications in a patient with primary sclerosing cholangitis
EJ Brandt, SM Regnier, EK Leung, SH Chou, BW Baron, HS Te, MH Davidson, RM Sargis 		Clinical Lipidology 2015
A kindred with fish eye disease, corneal opacities, marked high-density lipoprotein deficiency, and statin therapy
SM Dimick, B Sallee, BF Asztalos, PH Pritchard, J Frohlich, EJ Schaefer 		Journal of Clinical Lipidology 2014
LCAT, HDL Cholesterol and Ischemic Cardiovascular Disease: A Mendelian Randomization Study of HDL Cholesterol in 54,500 Individuals
CL Haase, A Tybjærg-Hansen, AA Qayyum, J Schou, BG Nordestgaard, R Frikke-Schmidt 		The Journal of clinical endocrinology and metabolism 2012
Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?
S Kunnen, MV Eck 		Journal of lipid research 2012
The role of lecithin:cholesterol acyltransferase in the modulation of cardiometabolic risks — A clinical update and emerging insights from animal models
DS Ng 		Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2012
Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?
S Kunnen, MV Eck 		Journal of lipid research 2012
Characterization of antioxidant/anti-inflammatory properties and apoA-I-containing subpopulations of HDL from family subjects with monogenic low HDL disorders
G Daniil, AA Phedonos, AG Holleboom, MM Motazacker, L Argyri, JA Kuivenhoven, A Chroni 		Clinica Chimica Acta 2011
Cornea
R Ursea, MT Feng, JA Smith 		Cornea 2011
Lecithin: cholesterol acyltransferase – from biochemistry to role in cardiovascular disease
X Rousset, B Vaisman, M Amar, AA Sethi, AT Remaley 		Current Opinion in Endocrinology, Diabetes and Obesity 2009
Lecithin: cholesterol acyltransferase--from biochemistry to role in cardiovascular disease
X Rousset, B Vaisman, M Amar, AA Sethi, AT Remaley 		Current opinion in endocrinology, diabetes, and obesity 2009
Inherited disorders of HDL metabolism and atherosclerosis
GK Hovingh, E Groot, W der Steeg, SM Boekholdt, BA Hutten, JA Kuivenhoven, JJ Kastelein 		Current Opinion in Lipidology 2005
Novel P143L polymorphism of the LCAT gene is associated with dyslipidemia in Chinese patients who have coronary atherosclerotic heart disease
K Zhang, S Zhang, K Zheng, Y Hou, L Liao, Y He, L Zhang, DW Nebert, J Shi, Z Su, C Xiao 		Biochemical and Biophysical Research Communications 2004
Genetic evaluation for coronary artery disease
MT Scheuner 		Genetics in Medicine 2003
Lecithin:cholesterol acyl transferase G30S: association with atherosclerosis, hypoalphalipoproteinemia and reduced in vivo enzyme activity
J Rosset, J Wang, BM Wolfe, PJ Dolphin, RA Hegele 		Clinical Biochemistry 2001
Probing the 121–136 Domain of Lecithin:Cholesterol Acyltransferase Using Antibodies
KR Murray, MP Nair, AF Ayyobi, JS Hill, PH Pritchard, AG Lacko 		Archives of Biochemistry and Biophysics 2001
Molecular genetics and gene expression in atherosclerosis
PA Doevendans, W Jukema, W Spiering, JC Defesche, JJ Kastelein 		International Journal of Cardiology 2001
Analysis of Glomerulosclerosis and Atherosclerosis in Lecithin Cholesterol Acyltransferase-deficient Mice
G Lambert, N Sakai, BL Vaisman, EB Neufeld, B Marteyn, CC Chan, B Paigen, E Lupia, A Thomas, LJ Striker, J Blanchette-Mackie, G Csako, JN Brady, R Costello, GE Striker, AT Remaley, HB Brewer, S Santamarina-Fojo 		The Journal of biological chemistry 2001
Cardiovascular Genetics for Clinicians
PA Doevendans, AA Wilde 		2001
Lecithin-cholesterol acyltransferase: role in lipoprotein metabolism, reverse cholesterol transport and atherosclerosis
S Santamarina-Fojo, G Lambert, JM Hoeg, HB Brewer 		Current Opinion in Lipidology 2000
Monogen bedingte Erbkrankheiten 1
D Ganten, K Ruckpaul 		2000
Relationship between structure and biochemical phenotype of lecithin:cholesterol acyltransferase (LCAT) mutants causing fish-eye disease
B Vanloo, F Peelman, K Deschuymere, J Taveirne, A Verhee, C Gouyette, C Labeur, J Vandekerckhove, J Tavernier, M Rosseneu 		Journal of lipid research 2000
Classical LCAT deficiency resulting from a novel homozygous dinucleotide deletion in exon 4 of the human lecithin: cholesterol acyltransferase gene causing a frameshift and stop codon at residue 144
EM Teh, JW Chisholm, PJ Dolphin, Y Pouliquen, M Savoldelli, JL Gennes, P Benlian 		Atherosclerosis 1999
A first British case of fish-eye disease presenting at age 75 years: a double heterozygote for defined and new mutations affecting LCAT structure and expression
AF Winder, JS Owen, PH Pritchard, D Lloyd-Jones, DT Vallance, P White, R Wray 		Journal of clinical pathology 1999
Effects of natural mutations in lecithin:cholesterol acyltransferase on the enzyme structure and activity
F Peelman, JL Verschelde, B Vanloo, C Ampe, C Labeur, J Tavernier, J Vandekerckhove, M Rosseneu 		Journal of lipid research 1999
T→G or T→A mutation introduced in the branchpoint consensus sequence of intron 4 of lecithin:cholesterol acyltransferase (LCAT) gene: intron retention causing LCAT deficiency
M Li 		Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1998
Transmission of two novel mutations in a pedigree with familial lecithin:cholesterol acyltransferase deficiency: structure–function relationships and studies in a compound heterozygous proband
G Argyropoulos, A Jenkins, RL Klein, T Lyons, B Wagenhorst, JS Armand, SM Marcovina, JJ Albers, PH Pritchard, WT Garvey 		Journal of lipid research 1998
Reverse Cholesterol Transport—A Review of the Process and Its Clinical Implications
SA Hill, MJ McQueen 		Clinical Biochemistry 1997
Fish-eye disease: Structural and in vivo metabolic abnormalities of high-density lipoproteins
L Elkhalil, Z Majd, R Bakir, O Perez-Mendez, G Castro, P Poulain, B Lacroix, N Duhal, JC Fruchart, G Luc 		Metabolism 1997
The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes
S Rust, M Rosier, H Funke, J Real, Z Amoura, JC Piette, JF Deleuze, HB Brewer, N Duverger, P Denèfle, G Assmann 		Journal of lipid research 1997
Familial lecithin:cholesterol acyltransferase deficiency: molecular analysis of a compound heterozygote: LCAT (Arg147→Trp) and LCAT (Tyr171→Stop)
M Guerin 		Atherosclerosis 1997
Molecular Basis of Fish-Eye Disease in a Patient From Spain: Characterization of a Novel Mutation in the LCAT Gene and Lipid Analysis of the Cornea
F Blanco-Vaca, SJ Qu, C Fiol, HZ Fan, Q Pao, A Marzal-Casacuberta, JJ Albers, I Hurtado, V Gracia, X Pintó, T Martí, HJ Pownall 		Arteriosclerosis, thrombosis, and vascular biology 1997
Catalytically inactive lecithin: cholesterol acyltransferase (LCAT) caused by a Gly 30 to Ser mutation in a family with LCAT deficiency
XP Yang, A Inazu, A Honjo, I Koizumi, K Kajinami, J Koizumi, SM Marcovina, JJ Albers, H Mabuchi 		Journal of lipid research 1997
An intronic mutation in a lariat branchpoint sequence is a direct cause of an inherited human disorder (fish-eye disease)
JA Kuivenhoven, H Weibusch, PH Pritchard, H Funke, R Benne, G Assmann, JJ Kastelein 		Journal of Clinical Investigation 1996

Advertisement